Skip to Content

WPI 3660 (Desvenlafaxine Succinate Extended-Release 100 mg (base))

Pill with imprint WPI 3660 is Orange, Four-sided and has been identified as Desvenlafaxine Succinate Extended-Release 100 mg (base). It is supplied by Actavis Pharma, Inc..

Desvenlafaxine is used in the treatment of major depressive disorder; depression; adhd; anxiety; bipolar disorder (and more), and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Desvenlafaxine 100 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3660

Desvenlafaxine succinate extended-release 100 mg (base) WPI 3660

Desvenlafaxine Succinate Extended-Release

Imprint:
WPI 3660
Strength:
100 mg (base)
Color:
Orange
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):
00591-3660

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide